REYON Pharmaceutical Co., Ltd. (KRX:102460)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,930
+530 (4.65%)
At close: Feb 20, 2026

REYON Pharmaceutical Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
218,808235,498303,360384,347631,111390,433
Market Cap Growth
-10.23%-22.37%-21.07%-39.10%61.64%47.64%
Enterprise Value
424,508381,553498,164550,681726,725401,156
Last Close Price
11930.0012840.0016540.0021444.7234972.8421582.97
PE Ratio
-56.7384.6652.23116.61101.56
PS Ratio
1.471.592.012.504.423.00
PB Ratio
0.940.941.221.552.571.70
P/TBV Ratio
0.940.951.231.562.591.71
P/OCF Ratio
--35.0944.0354.0184.89
EV/Sales Ratio
2.842.573.303.585.093.09
EV/EBITDA Ratio
-71.2176.0061.31117.0264.51
EV/EBIT Ratio
--281.00123.81470.45242.53
EV/FCF Ratio
-44.91-----
Debt / Equity Ratio
0.920.820.910.850.850.26
Debt / EBITDA Ratio
181.5038.0834.3323.4033.389.56
Net Debt / Equity Ratio
0.880.780.810.700.450.06
Net Debt / EBITDA Ratio
174.2536.1830.6419.3917.692.25
Net Debt / FCF Ratio
-21.76-11.11-9.93-3.20-1.04-0.29
Asset Turnover
0.310.300.310.320.360.44
Inventory Turnover
2.791.992.252.602.352.22
Quick Ratio
0.340.350.511.632.911.83
Current Ratio
0.600.660.802.273.472.42
Return on Equity (ROE)
-5.93%1.67%1.44%3.02%2.33%1.70%
Return on Assets (ROA)
-3.35%-0.12%0.22%0.58%0.24%0.35%
Return on Invested Capital (ROIC)
-5.92%-0.18%0.36%1.15%0.49%0.66%
Return on Capital Employed (ROCE)
-7.70%-0.30%0.50%1.00%0.40%0.60%
Earnings Yield
-6.51%1.76%1.18%1.93%0.88%0.98%
FCF Yield
-4.32%-7.41%-6.67%-14.16%-16.68%-12.22%
Dividend Yield
--0.91%0.70%0.71%0.93%
Payout Ratio
-66.27%76.41%61.38%62.56%150.47%
Buyback Yield / Dilution
-0.83%--0.46%-3.03%-4.05%-1.01%
Total Shareholder Return
-0.83%-0.45%-2.33%-3.34%-0.09%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.